Work

Supplementary Table 1 from Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer

Year: 2023

Type: supplementary-materials

Abstract: Clinical Outcomes with Various Third Generation EGFR Inhibitors

DOI: 10.1158/0008-5472.22422693

Authors: Ayesha Murtuza, Ajaz Bulbul, John Paul Shen, Parissa Keshavarzian, Brian D. Woodward, Fernando J. Lopez-Diaz, Scott M. Lippman, Hatim Husain

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362357076

Cites:

Cited by:

Related to: 10